JAVIER ALBERTO
CARBONE CAMPOVERDE
Profesor asociado de Ciencias de la Salud
Argitalpenak (109) JAVIER ALBERTO CARBONE CAMPOVERDE argitalpenak
2024
-
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report
Journal of clinical immunology, Vol. 44, Núm. 4, pp. 86
-
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
The Lancet Microbe, Vol. 5, Núm. 6, pp. e559-e569
-
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
European journal of medical research, Vol. 29, Núm. 1, pp. 418
2021
-
How suitable is intravenous tocilizumab for the treatment of Graves’ ophthalmopathy?
Expert Review of Clinical Immunology
-
Immunologic Abnormalities Associated With Health Status of Heart Recipients Long Term After Transplantation
Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2724-2727
-
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
Journal of Allergy and Clinical Immunology, Vol. 148, Núm. 5, pp. 1332-1341.e5
-
Metabolite profiles associated with disease progression in influenza infection
PLoS ONE, Vol. 16, Núm. 4 April
-
Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study
Transplant Infectious Disease, Vol. 23, Núm. 2
2020
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347
-
Preliminary Results of a Randomized Clinical Trial of Intravenous Immunoglobulin in Solid Organ Recipients with Severe Infection and Secondary Antibody Deficiency
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Vol. 39, Núm. 4, pp. S45-S46
2019
-
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 11, pp. 951-963
-
Primary and secondary immunodeficiency diseases in oncohaematology: Warning signs, diagnosis, and management
Frontiers in Immunology, Vol. 10, Núm. MAR
-
Secondary Antibody Deficiency in a Heart Recipient with Systemic Aspergillosis
OBM Transplantation, Vol. 3, Núm. 1
-
The expanding field of secondary antibody deficiency: Causes, diagnosis, and management
Frontiers in Immunology, Vol. 10, Núm. FEB
2018
-
Complement genomics and antibody-mediated rejection in heart recipients
Journal of Heart and Lung Transplantation
-
Infections in patients after Berlin Heart® EXCOR assist device implantation
Transplant Infectious Disease, Vol. 20, Núm. 5
-
Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: A multicenter prospective study
Journal of Heart and Lung Transplantation, Vol. 37, Núm. 8, pp. 1001-1012
2017
-
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study
Journal of Heart and Lung Transplantation, Vol. 36, Núm. 5, pp. 529-539
2016
-
Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial
Transplant Infectious Disease, Vol. 18, Núm. 6, pp. 832-843